CanSino coronavirus vaccine clears mid-stage test, but data show its limits

Vaccination with an experimental shot developed by China's CanSino Biologics led to immune responses in nearly all of 508 healthy volunteers enrolled in a mid-stage study, data published Monday in The Lancet show.